Development of neutralizing monoclonal antibodies for oncogenic human papillomavirus types 31, 33, 45, 52, and 58
about
Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteinsPre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteinsPhase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine.Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.Functional assessment and structural basis of antibody binding to human papillomavirus capsid.Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials.Expanded strain coverage for a highly successful public health tool: prophylactic 9-valent human papillomavirus vaccine.Escherichia coli-derived virus-like particles in vaccine development.9-Valent human papillomavirus vaccine: a review of the clinical development program.Development and characterization of an HPV18 detection kit using two novel HPV18 type-specific monoclonal antibodies
P2860
Q27013018-CFAAA496-B419-4F2E-B7A1-82CEA92F6867Q34492140-76C67EA5-42C8-4724-B881-6A8BE3F1E435Q35887777-0C151EDB-6E4E-4E69-A331-7090E79938BDQ38271441-D68DED2E-2666-45B9-A33C-1B7BECFE460DQ38586257-840F5B91-E7E4-4165-A19C-A3E14CB1F4F6Q38671633-1AA01335-9CDF-4F3D-BC35-A596AEB5CDAFQ38673370-0429A9A5-CD3B-4731-AE9D-1F68B5105039Q38682763-7ED98C9A-1B69-4072-9378-FDCA23E08353Q47132009-87EC7A95-50E3-4AD2-AA77-AF4DE5960126Q49687633-0AE1793C-937F-45A7-AA0A-9EEB33CFFE52Q58771886-6D1861B5-0471-41BA-974D-7A72FD1430CD
P2860
Development of neutralizing monoclonal antibodies for oncogenic human papillomavirus types 31, 33, 45, 52, and 58
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of neutralizing mo ...... s types 31, 33, 45, 52, and 58
@en
Development of neutralizing mo ...... types 31, 33, 45, 52, and 58.
@nl
type
label
Development of neutralizing mo ...... s types 31, 33, 45, 52, and 58
@en
Development of neutralizing mo ...... types 31, 33, 45, 52, and 58.
@nl
prefLabel
Development of neutralizing mo ...... s types 31, 33, 45, 52, and 58
@en
Development of neutralizing mo ...... types 31, 33, 45, 52, and 58.
@nl
P2093
P2860
P356
P1476
Development of neutralizing mo ...... s types 31, 33, 45, 52, and 58
@en
P2093
Adam C Finnefrock
Hanna Seitz
Martha J Brown
Martin Müller
Victoria Towne
P2860
P304
P356
10.1128/CVI.00773-13
P577
2014-02-26T00:00:00Z